gastric neoplasm
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Preoperatively, (1) histologically proven adenocarcinoma, (2)T1, and 4cm or less in diameter, no tumor within 2cm from esophagogastric junction or pyloric ring, (3) no existence of multiple foci, (4) no prior treatment for gastric cancer, (5) no prior surgery for gastric or duodenal ulcer (6) written informed consent. Intra-operatively, (7) prior to dye injection, (8) not laparoscopic surgery, (9) T1, (10) palpable of tumor or marking clips, (11) no apparent lymph node metastasis, (12) no severe adhesion around stomach.
Exclusion criteria
Exclusion criteria: (1) anaphylaxis reaction against iodine, (2) non-curative synchronous malignancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| False-negative rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Success rate, false-positive rate, post-operative morbidity, anaphylaxis reaction, relapse-free survival of patients with lymph node metastases | — |
Countries
Japan
Contacts
JCOG0302 Coordinating Office Gastric Surgery Division, Osaka Medical Center for Cancer and Cardiovascular Diseases